Cardiac alterations in human African trypanosomiasis (T.b. gambiense) with respect to the disease stage and antiparasitic treatment.
BACKGROUND
In Human African Trypanosomiasis, neurological symptoms dominate and cardiac involvement has been suggested. Because of increasing resistance to the available drugs for HAT, new compounds are desperately needed. Evaluation of cardiotoxicity is one parameter of drug safety, but without knowledge of the baseline heart involvement in HAT, cardiologic findings and drug-induced alterations will be difficult to interpret. The aims of the study were to assess the frequency and characteristics of electrocardiographic findings in the first stage of HAT, to compare these findings to those of second stage patients and healthy controls and to assess any potential effects of different therapeutic antiparasitic compounds with respect to ECG changes after treatment.


METHODS
Four hundred and six patients with first stage HAT were recruited in the Democratic Republic of Congo, Angola and Sudan between 2002 and 2007 in a series of clinical trials comparing the efficacy and safety of the experimental treatment DB289 to the standard first stage treatment, pentamidine. These ECGs were compared to the ECGs of healthy volunteers (n = 61) and to those of second stage HAT patients (n = 56).


RESULTS
In first and second stage HAT, a prolonged QTc interval, repolarization changes and low voltage were significantly more frequent than in healthy controls. Treatment in first stage was associated with repolarization changes in both the DB289 and the pentamidine group to a similar extent. The QTc interval did not change during treatment.


CONCLUSIONS
Cardiac involvement in HAT, as demonstrated by ECG alterations, appears early in the evolution of the disease. The prolongation of the QTC interval comprises a risk of fatal arrhythmias if new drugs with an additional potential of QTC prolongation will be used. During treatment ECG abnormalities such as repolarization changes consistent with peri-myocarditis occur frequently and appear to be associated with the disease stage, but not with a specific drug.
Blum
Johannes A
JA
Swiss Tropical Institute, Basel, Switzerland.
Schmid
Caecilia
C
Burri
Christian
C
Hatz
Christoph
C
Olson
Carol
C
Fungula
Blaise
B
Kazumba
Leon
L
Mangoni
Patrick
P
Mbo
Florent
F
Deo
Kambau
K
Mpanya
Alain
A
Dala
Amadeo
A
Franco
Jose R
JR
Pohlig
Gabriele
G
Zellweger
Michael J
MJ
D000328:Adult; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000209:etiology; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000139:chemically induced* / Q000209:etiology*; D006801:Humans; D008297:Male; D014344:Trypanocidal Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D014353:Trypanosomiasis, African / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology*
D014344:Trypanocidal Agents